DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 3.20% to $1.21 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.01% to 26,939.37 and the Dow Jones Industrial Average falling 0.31% to 51,349.98.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 55.51% below its 52-week high of $2.72, which the company reached on December 17th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.56% to $270.68, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.82% to $28.41.
Trading volume (2.9 M) remained 1.4 million below its 50-day average volume of 4.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.
Comments